Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Univo Pharmaceuticals Ltd
  6. News
  7. Summary
    UNVO   IL0010935588

UNIVO PHARMACEUTICALS LTD

(UNVO)
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Univo Pharmaceuticals Ltd Reports Earnings Results for the Half Year Ended June 30, 2021

08/31/2021 | 05:50am EST

Univo Pharmaceuticals Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was ILS 19.322 million compared to ILS 10.141 million a year ago. Operating income was ILS 5.061 million compared to ILS 493,000 a year ago. Net income was ILS 182,000 compared to ILS 96,000 a year ago. Basic earnings per share from continuing operations was ILS 0.01.


ę S&P Capital IQ 2021
All news about UNIVO PHARMACEUTICALS LTD
08/31Univo Pharmaceuticals Ltd Reports Earnings Results for the Half Year Ended June 30, 202..
CI
2020Can-Fite Biopharma Ltd. Announces New Pre-Clinical Findings in Connection with its On-G..
CI
2020Can-Fite Biopharma Ltd and Univo Pharmaceuticals Ltd Collaboration Result in Discovery ..
CI
2019Univo Pharmaceuticals Ltd announced that it expects to receive ILS 5.994553 million in ..
CI
2019Can-Fite Enters into Strategic Agreement with Univo Pharmaceuticals to Develop Cannabin..
CI
2019Univo Pharmaceuticals Ltd announced that it expects to receive ILS 2.499999 million in ..
CI
2019Univo Pharmaceuticals Ltd announced that it has received ILS 3 million in funding
CI
2019UNV Medicine LTD. announced that it has received ILS 6 million in funding from Hagag Gr..
CI
2018UNV-Medicine Signs New Deal with Israeli Cannabis Startup
CI
2018UNV Medicine Ltd. completed the acquisition of D-Pharm LTD. in a reverse merger transac..
CI
More news
Financials
Sales 2019 0,82  0,26  0,26 
Net income 2019 -11,8 M -3,73 M -3,73 M
Net cash 2019 22,8 M 7,22 M 7,22 M
P/E ratio 2019 -5,92x
Yield 2019 -
Capitalization 64,3 M 20,3 M 20,3 M
EV / Sales 2018 -
EV / Sales 2019 35 568 323x
Nbr of Employees -
Free-Float 59,6%
Chart UNIVO PHARMACEUTICALS LTD
Duration : Period :
Univo Pharmaceuticals Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Golan Bitton Chief Executive Officer & Director
Moran Attar Yossef Chief Financial Officer
Chaim Hurvitz Chairman
Meital Ran Zohara Independent Director
Ahuva Shelly Harpaz Greenberg Independent External Director
Sector and Competitors
1st jan.Capi. (M$)
UNIVO PHARMACEUTICALS LTD-20.34%20
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
IQVIA HOLDINGS INC.46.05%49 991
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-42.48%24 298